• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镥[177Lu]-DOTATATE 治疗后扫描见胆囊摄取,类似肝脏转移

Gallbladder Uptake Mimicking Liver Metastasis on 177Lu-DOTATATE Posttherapy Scan Gallbladder Uptake on 177Lu-DOTATATE Scan.

机构信息

From the Department of Nuclear Medicine, Ankara University Medical School, Ankara.

Department of Medical Oncology, Demiroglu Bilim University, Istanbul.

出版信息

Clin Nucl Med. 2021 Mar 1;46(3):e154-e155. doi: 10.1097/RLU.0000000000003475.

DOI:10.1097/RLU.0000000000003475
PMID:33512839
Abstract

We represent the case of a 61-year-old man with atypical carcinoid tumor of the lung. On posttherapy 177Lu-DOTATATE whole-body scan, focal intense uptake in the inferomedial side of the liver was detected. Pretherapy 68Ga-DOTATATE PET/CT showed no sign of liver metastasis, and posttherapy diagnostic dynamic liver MRI is used to exclude metastatic liver disease. Focal intense uptake was attributed to physiological gallbladder uptake.

摘要

我们报告了一例 61 岁男性患有非典型肺类癌肿瘤的病例。在治疗后 177Lu-DOTATATE 全身扫描中,发现肝脏中内侧下方有局灶性摄取增强。治疗前 68Ga-DOTATATE PET/CT 未显示肝转移的迹象,治疗后使用诊断性动态肝脏 MRI 排除肝转移疾病。局灶性摄取增强归因于生理性胆囊摄取。

相似文献

1
Gallbladder Uptake Mimicking Liver Metastasis on 177Lu-DOTATATE Posttherapy Scan Gallbladder Uptake on 177Lu-DOTATATE Scan.镥[177Lu]-DOTATATE 治疗后扫描见胆囊摄取,类似肝脏转移
Clin Nucl Med. 2021 Mar 1;46(3):e154-e155. doi: 10.1097/RLU.0000000000003475.
2
Gallbladder Visualization in Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE: A Potential Mimicker of Hepatic Metastases.177Lu-DOTATATE 肽受体放射性核素治疗中胆囊显影:肝转移的潜在类似物。
Clin Nucl Med. 2020 Dec;45(12):e521-e522. doi: 10.1097/RLU.0000000000003192.
3
Hepatopulmonary Shunt Reduction With 177Lu-DOTATATE Therapy.177Lu-DOTATATE 治疗减少肝肺分流。
Clin Nucl Med. 2016 Nov;41(11):866-871. doi: 10.1097/RLU.0000000000001352.
4
Discordant Uptake Between Diagnostic 68Ga-HA-DOTATATE PET/CT and Posttherapy 177Lu-HA-DOTATATE SPECT/CT in Patients With Neuroendocrine Tumors.神经内分泌肿瘤患者诊断性 68Ga-HA-DOTATATE PET/CT 与治疗后 177Lu-HA-DOTATATE SPECT/CT 摄取的不协调性。
Clin Nucl Med. 2021 Sep 1;46(9):e475-e477. doi: 10.1097/RLU.0000000000003618.
5
Clinical Assessment of 177Lu-DOTATATE Quantification by Comparison of SUV-Based Parameters Measured on Both Post-PRRT SPECT/CT and 68Ga-DOTATOC PET/CT in Patients With Neuroendocrine Tumors: A Feasibility Study.比较神经内分泌肿瘤患者 PRRT 后 SPECT/CT 和 68Ga-DOTATOC PET/CT 上基于 SUV 的参数,评估 177Lu-DOTATATE 的临床定量:一项可行性研究。
Clin Nucl Med. 2021 Feb 1;46(2):111-118. doi: 10.1097/RLU.0000000000003412.
6
Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.奥曲肽受体显像在非(131)I 摄取的转移性分化型甲状腺癌中评估(177)Lu-DOTATATE 肽受体放射性核素治疗的可行性:适合肽受体放射性核素治疗的患者比例较低,且存在嗜铬粒蛋白 A 水平阳性神经内分泌分化的证据。
Clin Nucl Med. 2014 Jun;39(6):505-10. doi: 10.1097/RLU.0000000000000429.
7
Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.基于¹⁷⁷Lu-DOTATATE的肽受体放射性核素治疗在转移性胃肠胰神经内分泌肿瘤中的应用:一项与原发肿瘤部位、肿瘤增殖指数及双示踪剂成像特征相关的多参数反应评估
Nucl Med Commun. 2016 Oct;37(10):1030-7. doi: 10.1097/MNM.0000000000000547.
8
68Ga-DOTATATE PET/CT in Focal Fatty Sparing of the Liver.68Ga-DOTATATE PET/CT 对肝脏局灶性脂肪保留的诊断价值
Clin Nucl Med. 2019 Oct;44(10):815-817. doi: 10.1097/RLU.0000000000002746.
9
Malignant insulinoma: 18F-DOPA and 68Ga-DOTATATE PET/CT and treatment with 177Lu-DOTATATE.恶性胰岛素瘤:18F-DOPA和68Ga-DOTATATE PET/CT以及177Lu-DOTATATE治疗
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Nov-Dec;39(6):383-386. doi: 10.1016/j.remn.2019.12.002. Epub 2020 May 30.
10
Additional lesions detected in therapeutic scans with 177Lu-DOTATATE reflect higher affinity of 177Lu-DOTATATE for somatostatin receptors. 治疗性扫描中发现的其他病变反映了 177Lu-DOTATATE 对生长抑素受体的更高亲和力。
Oncology. 2011;80(5-6):326-9. doi: 10.1159/000329808. Epub 2011 Jul 25.

引用本文的文献

1
Incidental Visualization of Gallbladder on Post-therapy [ Lu]Lu-DOTATATE Scintigraphy Mimicking a Liver Metastasis in a Duodenal Neuroendocrine Tumor.治疗后[镥]镥-奥曲肽闪烁扫描中胆囊的偶然显影,酷似十二指肠神经内分泌肿瘤的肝转移。
World J Nucl Med. 2024 Jul 4;23(4):292-294. doi: 10.1055/s-0044-1788073. eCollection 2024 Dec.